AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vildascan M 500mg/50mg Tablet

Prescription Icon
Prescription Required

Marketer

Medishri Healthcare

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Vildascan M 500mg/50mg Tablet

Combiflor 500mg/50mg tablets effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual-action medication mitigates severe diabetic complications like nephropathy and retinopathy, potentially lowering cardiovascular event risk. Combiflor 500mg/50mg may be administered independently or in conjunction with other antidiabetic agents. Optimal efficacy necessitates adherence to a balanced diet and regular physical activity. Dosage is individualized based on your health status, glycemic control, and concurrent medications. Consuming it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefit; discontinuation should only occur under physician guidance. This treatment regulates blood sugar, preventing future complications. Continued adherence to your prescribed diet and exercise regimen is crucial for diabetes management; lifestyle modifications significantly impact disease control. Commonly reported adverse effects include diarrhea, nausea, vomiting, dyspepsia, cephalalgia, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia, particularly when combined with insulin or sulfonylureas, is a potential risk requiring prompt recognition and management. This medication isn't universally suitable. Prior to initiation, inform your physician of any pre-existing renal, hepatic, or cardiac conditions, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating individuals should consult their doctor before use. Potential drug interactions necessitate complete disclosure of all medications to ensure patient safety. Alcohol consumption should be minimized due to its hypoglycemic effects. Your doctor will monitor renal function and blood glucose levels throughout your treatment.

Primary Ingredients of Vildascan M 500mg/50mg Tablet

No text provided. Please provide the text you wish me to rephrase.

Uses of Vildascan M 500mg/50mg Tablet

Managing type 2 diabetes

Major Benefits of Vildascan M 500mg/50mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the Vildascan M 500mg/50mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.

Common Side effects of Vildascan M 500mg/50mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vildascan M 500mg/50mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Vildascan M 500mg/50mg tablets should be administered with a meal.

How Vildascan M 500mg/50mg Tablet works:

Each Vildascan M tablet (500mg/50mg) contains a dual antidiabetic drug formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use and Vildascan M 500mg/50mg Tablet is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Vildascan M 500mg/50mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice before use.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Vildascan M 500mg/50mg tablets while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.

KidneyKidneyCAUTION

Patients with kidney impairment should use Vildascan M 500mg/50mg tablets cautiously. Dosage modification may be necessary; physician consultation is recommended.

LiverLiverUNSAFE

The use of Vildascan M 500mg/50mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Vildascan M 500mg/50mg Tablet :

Should you forget a Vildascan M 500mg/50mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual regimen. Avoid taking a double dose.

Facts to Know About Vildascan M 500mg/50mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Vildascan M 500mg/50mg Tablet

Vildascan M 500mg/50mg Tablets rarely cause hypoglycemia by themselves. However, low blood sugar can result from inadequate caloric intake while using this medication. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, and shakiness. These symptoms are more pronounced if meals are missed or delayed, alcohol is consumed, excessive exercise is undertaken, or other antidiabetic medications are used concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Vildascan M 500mg/50mg Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without your doctor's approval.
Vildascan M 500mg/50mg Tablets are contraindicated in patients allergic to any ingredient. This medication is also harmful for those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Vildascan M 500mg/50mg tablets combine the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Vildascan M 500mg/50mg Tablets can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue use and seek immediate medical attention.
Prolonged use of Vildascan M 500mg/50mg Tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia and neurological complications.
Vildascan M 500mg/50mg Tablet is safe when used as directed by your doctor. However, even with proper usage, you may experience side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (hypoglycemia, especially if also taking insulin or sulphonylurea). Report any persistent issues to your doctor.
Vildascan M 500mg/50mg Ta...
112
MRP 130
13% off